LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Buparlisib | 0.12 | uM | LJP5 | 1 | H05 | 72 | hr | 2543 | 4814 | 5734 | 0.8395 | 0.7228 |
| SK-BR-3 | Buparlisib | 0.12 | uM | LJP5 | 2 | H05 | 72 | hr | 2543 | 4654 | 5761 | 0.8078 | 0.6690 |
| SK-BR-3 | Buparlisib | 0.12 | uM | LJP5 | 3 | H05 | 72 | hr | 2543 | 4853 | 5760 | 0.8424 | 0.7294 |
| SK-BR-3 | Buparlisib | 0.37 | uM | LJP5 | 1 | H04 | 72 | hr | 2543 | 2710 | 5734 | 0.4726 | 0.0556 |
| SK-BR-3 | Buparlisib | 0.37 | uM | LJP5 | 2 | H04 | 72 | hr | 2543 | 2918 | 5761 | 0.5065 | 0.1235 |
| SK-BR-3 | Buparlisib | 0.37 | uM | LJP5 | 3 | H04 | 72 | hr | 2543 | 3192 | 5760 | 0.5541 | 0.2124 |
| SK-BR-3 | Buparlisib | 1.11 | uM | LJP5 | 1 | H03 | 72 | hr | 2543 | 1456 | 5734 | 0.2539 | -0.3785 |
| SK-BR-3 | Buparlisib | 1.11 | uM | LJP5 | 2 | H03 | 72 | hr | 2543 | 1317 | 5761 | 0.2286 | -0.4276 |
| SK-BR-3 | Buparlisib | 1.11 | uM | LJP5 | 3 | H03 | 72 | hr | 2543 | 1587 | 5760 | 0.2755 | -0.3296 |
| SK-BR-3 | Buparlisib | 3.33 | uM | LJP5 | 1 | H02 | 72 | hr | 2543 | 1213 | 5734 | 0.2115 | -0.4681 |
| SK-BR-3 | Buparlisib | 3.33 | uM | LJP5 | 2 | H02 | 72 | hr | 2543 | 1411 | 5761 | 0.2449 | -0.3932 |
| SK-BR-3 | Buparlisib | 3.33 | uM | LJP5 | 3 | H02 | 72 | hr | 2543 | 1221 | 5760 | 0.2120 | -0.4632 |
| SK-BR-3 | Buparlisib | 10 | uM | LJP5 | 1 | H01 | 72 | hr | 2543 | 1239 | 5734 | 0.2161 | -0.4584 |
| SK-BR-3 | Buparlisib | 10 | uM | LJP5 | 2 | H01 | 72 | hr | 2543 | 1207 | 5761 | 0.2095 | -0.4684 |
| SK-BR-3 | Buparlisib | 10 | uM | LJP5 | 3 | H01 | 72 | hr | 2543 | 1221 | 5760 | 0.2120 | -0.4632 |
| SK-BR-3 | XL147 | 0.04 | uM | LJP5 | 1 | G12 | 72 | hr | 2543 | 6198 | 5734 | 1.0808 | 1.1370 |
| SK-BR-3 | XL147 | 0.04 | uM | LJP5 | 2 | G12 | 72 | hr | 2543 | 6264 | 5761 | 1.0872 | 1.1469 |
| SK-BR-3 | XL147 | 0.04 | uM | LJP5 | 3 | G12 | 72 | hr | 2543 | 6032 | 5760 | 1.0471 | 1.0795 |
| SK-BR-3 | XL147 | 0.12 | uM | LJP5 | 1 | G11 | 72 | hr | 2543 | 6012 | 5734 | 1.0484 | 1.0822 |
| SK-BR-3 | XL147 | 0.12 | uM | LJP5 | 2 | G11 | 72 | hr | 2543 | 6028 | 5761 | 1.0463 | 1.0782 |
| SK-BR-3 | XL147 | 0.12 | uM | LJP5 | 3 | G11 | 72 | hr | 2543 | 5690 | 5760 | 0.9877 | 0.9791 |
| SK-BR-3 | XL147 | 0.37 | uM | LJP5 | 1 | G10 | 72 | hr | 2543 | 5837 | 5734 | 1.0179 | 1.0304 |
| SK-BR-3 | XL147 | 0.37 | uM | LJP5 | 2 | G10 | 72 | hr | 2543 | 5673 | 5761 | 0.9847 | 0.9740 |
| SK-BR-3 | XL147 | 0.37 | uM | LJP5 | 3 | G10 | 72 | hr | 2543 | 5777 | 5760 | 1.0028 | 1.0048 |
| SK-BR-3 | XL147 | 1.11 | uM | LJP5 | 1 | G09 | 72 | hr | 2543 | 5777 | 5734 | 1.0074 | 1.0126 |